• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

良性前列腺增生中的前列腺炎症——第三个组成部分?

Prostatic inflammation in benign prostatic hyperplasia - the third component?

作者信息

Nickel J C

机构信息

Department of Urology, Queen's University and Kingston General Hospital, Kingston, Ontario.

出版信息

Can J Urol. 1994 Jan;1(1):1-4.

PMID:12834558
Abstract

The etiology, diagnosis, therapy and treatment outcome of the two most common nonmalignant disease of the prostate remain problematic. Benign prostatic hyperplasia and prostatic inflammation can coexist yet these conditions have been studied in almost complete isolation. The author develops the hypothesis that prostatic inflammation (prostatitis) can influence the clinical presentation and perhaps surgical outcome in patients treated for symptomatic benign prostatic hyperplasia.

摘要

前列腺两种最常见的非恶性疾病的病因、诊断、治疗及治疗结果仍然存在问题。良性前列腺增生和前列腺炎可能并存,但对这些病症的研究几乎是完全孤立进行的。作者提出一个假说,即前列腺炎可能会影响有症状的良性前列腺增生患者的临床表现,甚至可能影响手术效果。

相似文献

1
Prostatic inflammation in benign prostatic hyperplasia - the third component?良性前列腺增生中的前列腺炎症——第三个组成部分?
Can J Urol. 1994 Jan;1(1):1-4.
2
Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia.评估前列腺分泌物中白细胞介素-8作为良性前列腺增生炎症可靠生物标志物的作用。
Urology. 2009 Aug;74(2):340-4. doi: 10.1016/j.urology.2009.02.064. Epub 2009 May 22.
3
Clinical approach to the prostate: an update.前列腺的临床诊疗方法:最新进展
Radiol Clin North Am. 2006 Sep;44(5):649-63, vii. doi: 10.1016/j.rcl.2006.07.003.
4
[Further studies on the relationship between benign prostatic hyperplasia and prostatitis].[良性前列腺增生与前列腺炎关系的进一步研究]
Zhonghua Nan Ke Xue. 2004 Feb;10(2):83-5.
5
Prevention of benign prostatic hyperplasia disease.良性前列腺增生症的预防。
J Urol. 2006 Oct;176(4 Pt 1):1299-306. doi: 10.1016/j.juro.2006.06.022.
6
A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.一项关于前列腺光选择性汽化术与其他微创治疗方法及经尿道前列腺切除术治疗良性前列腺增生的临床结果和成本分析。
J Urol. 2006 Oct;176(4 Pt 1):1500-6. doi: 10.1016/j.juro.2006.06.064.
7
Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems.良性前列腺增生和下尿路症状的可改变风险因素:老问题的新方法
J Urol. 2007 Aug;178(2):395-401. doi: 10.1016/j.juro.2007.03.103. Epub 2007 Jun 11.
8
Could inflammation be a key component in the progression of benign prostatic hyperplasia?炎症会是良性前列腺增生进展过程中的关键因素吗?
Curr Opin Urol. 2006 Jan;16(1):25-9.
9
Post-prostatic massage examination for prediction of asymptomatic prostatitis in needle biopsies: a prospective study.经前列腺按摩检查对预测经针穿刺活检无症状前列腺炎的前瞻性研究
J Urol. 2009 Aug;182(2):564-8; discussion 568-9. doi: 10.1016/j.juro.2009.04.009. Epub 2009 Jun 13.
10
[Role of apoptosis and chronic prostatitis in the pathogenesis of benign prostatic hyperplasia].
Pol Merkur Lekarski. 2004 Oct;17(100):307-10.

引用本文的文献

1
Alleviates Progression of Benign Prostatic Hyperplasia in vitro and in vivo.在体外和体内均能缓解良性前列腺增生的进展。
Res Rep Urol. 2022 Sep 24;14:313-326. doi: 10.2147/RRU.S381713. eCollection 2022.
2
Can Botulinum Toxin A Still Have a Role in Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Through Inhibition of Chronic Prostatic Inflammation?A型肉毒杆菌毒素能否通过抑制慢性前列腺炎仍在治疗下尿路症状/良性前列腺增生中发挥作用?
Toxins (Basel). 2019 Sep 19;11(9):547. doi: 10.3390/toxins11090547.
3
The effect of prostatic inflammation on clinical outcomes in patients with benign prostate hyperplasia.
前列腺炎症对良性前列腺增生患者临床结局的影响。
Prostate Int. 2018 Jun;6(2):71-74. doi: 10.1016/j.prnil.2017.12.003. Epub 2018 Jan 8.
4
Inflammation in Prostatic Hyperplasia and Carcinoma-Basic Scientific Approach.前列腺增生和癌中的炎症——基础科学方法
Front Oncol. 2017 Apr 25;7:77. doi: 10.3389/fonc.2017.00077. eCollection 2017.
5
Metabolic syndrome, inflammation and lower urinary tract symptoms: possible translational links.代谢综合征、炎症与下尿路症状:可能的转化关联
Prostate Cancer Prostatic Dis. 2016 Mar;19(1):7-13. doi: 10.1038/pcan.2015.43. Epub 2015 Sep 22.
6
Diagnostic investigations of canine prostatitis incidence together with benign prostate hyperplasia, prostate malignancies, and biochemical recurrence in high-risk prostate cancer as a model for human study.作为人类研究模型,对犬前列腺炎发病率以及良性前列腺增生、前列腺恶性肿瘤和高危前列腺癌生化复发的诊断研究。
Tumour Biol. 2015 Apr;36(4):2437-45. doi: 10.1007/s13277-014-2854-4. Epub 2014 Nov 25.
7
Effect of prostatitis on lower urinary tract symptoms: retrospective analysis of prostate biopsy tissue.前列腺炎对下尿路症状的影响:前列腺活检组织的回顾性分析
Korean J Urol. 2012 Feb;53(2):109-13. doi: 10.4111/kju.2012.53.2.109. Epub 2012 Feb 20.
8
Role of inflammation in benign prostatic hyperplasia.炎症在良性前列腺增生中的作用。
Rev Urol. 2011;13(3):147-50.
9
Models of inflammation of the lower urinary tract.下尿路炎症模型。
Neurourol Urodyn. 2011 Jun;30(5):673-82. doi: 10.1002/nau.21078.
10
Inflammation and benign prostatic hyperplasia: clinical implications.炎症与良性前列腺增生:临床意义。
Curr Urol Rep. 2011 Aug;12(4):274-7. doi: 10.1007/s11934-011-0191-3.